These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32782136)

  • 1. The Unmet Medical Needs of Current Injectable Antidiabetic Therapies in China: Patient and Health Care Professional Perspectives.
    Chen T; Zhou L; Wang K; Ma X; Wu H; Liu X; Tong J; Cai B; Ji Q
    Clin Ther; 2020 Aug; 42(8):1549-1563. PubMed ID: 32782136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Characteristics Between Chinese Patients Taking Glucagon-like Peptide 1 Receptor Agonists and Insulin: A Cross-sectional Database Analysis.
    Wang K; Chen Y; Strizek A; Boye K; Gu L; Liu Y; Qu S
    Clin Ther; 2019 Oct; 41(10):2057-2065. PubMed ID: 31514971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A discrete-choice experiment to quantify patient preferences for frequency of glucagon-like peptide-1 receptor agonist injections in the treatment of type 2 diabetes.
    Hauber AB; Nguyen H; Posner J; Kalsekar I; Ruggles J
    Curr Med Res Opin; 2016; 32(2):251-62. PubMed ID: 26549576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, worry and discussion about dosing irregularities and self-treated hypoglycaemia amongst HCPs and patients with type 2 diabetes: results from the UK cohort of the Global Attitudes of Patient and Physicians (GAPP2) survey.
    Munro N; Barnett AH
    Int J Clin Pract; 2014 Jun; 68(6):692-9. PubMed ID: 24548693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden of hypoglycemia on healthcare utilization, costs, and quality of life among type 2 diabetes mellitus patients.
    Williams SA; Shi L; Brenneman SK; Johnson JC; Wegner JC; Fonseca V
    J Diabetes Complications; 2012; 26(5):399-406. PubMed ID: 22699113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of a new disposable insulin pen and injection habits of diabetes patients in everyday clinical practice].
    Böhler S; Landgraf W; Schreiber SA
    MMW Fortschr Med; 2010 Jan; 151 Suppl 4():179-87. PubMed ID: 21595146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment: Using Combinations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist.
    Baron HL
    J Fam Pract; 2017 Oct; 66(10 Suppl):S17-S28. PubMed ID: 28991933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. User Satisfaction and Insulin Pump Handling With a Prefilled Insulin Cartridge in Adults and Adolescents With Type 1 Diabetes.
    Gupta J; Fuchs GS; Jenkins M; van Geel B; Jensen ML; Sparre T
    J Diabetes Sci Technol; 2020 Jan; 14(1):97-104. PubMed ID: 31113250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed-ratio combination therapy for type 2 diabetes: the top ten things you should know about insulin and glucagon-like peptide-1 receptor agonist combinations.
    Blumer I; Pettus JH; Santos Cavaiola T
    Postgrad Med; 2018 May; 130(4):375-380. PubMed ID: 29521173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adherence of type 2 diabetes patients on insulin analogues application: missed dose, time imprecision and dose reduction. The results of GAPP2TM(Global Attitudes of Physicians and Patient) survey in the Czech Republic].
    Prázný M
    Vnitr Lek; 2014 Nov; 60(11):999-1006. PubMed ID: 25600048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How do health care professionals assess patients when initiating insulin therapy? A qualitative study.
    Lee PY; Lee YK; Khoo EM; Ng CJ
    Prim Care Diabetes; 2014 Apr; 8(1):49-55. PubMed ID: 24315732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to insulin injection therapy: patient and health care provider perspectives.
    Rubin RR; Peyrot M; Kruger DF; Travis LB
    Diabetes Educ; 2009; 35(6):1014-22. PubMed ID: 19934459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Unmet needs in the therapy of type 2 diabetes mellitus. How can barriers to insulin therapy be overcome?].
    Aberle J
    MMW Fortschr Med; 2023 Jul; 165(Suppl 4):3-11. PubMed ID: 37415032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes injectable therapy: type 2 diabetes management in Danish practice.
    Sterzi D; Auziere S; Jensen MM; Lopes S
    Curr Med Res Opin; 2017 Dec; 33(12):2211-2216. PubMed ID: 28875722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to insulin initiation in elderly patients with type 2 diabetes mellitus in Brazil.
    Eliaschewitz FG; de Paula MA; Pedrosa HC; Pires AC; Salles JEN; Tambascia MA; A Turatti LA
    Diabetes Metab Syndr; 2018; 12(1):39-44. PubMed ID: 28864058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in depression, treatment satisfaction and injection behaviour in adults with type 1 diabetes and different degrees of lipohypertrophy.
    Hernar I; Haltbakk J; Broström A
    J Clin Nurs; 2017 Dec; 26(23-24):4583-4596. PubMed ID: 28295770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization.
    Cooke CE; Lee HY; Tong YP; Haines ST
    Curr Med Res Opin; 2010 Jan; 26(1):231-8. PubMed ID: 19921965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albiglutide: A once-weekly glucagon-like peptide-1 receptor agonist for type 2 diabetes mellitus.
    Davis PN; Ndefo UA; Oliver A; Payton E
    Am J Health Syst Pharm; 2015 Jul; 72(13):1097-103. PubMed ID: 26092960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk perceptions of patients with type 2 diabetes mellitus regarding insulin therapy and diabetes complications: A cross-sectional study.
    Sağlam FS; Bektas H
    J Clin Nurs; 2023 Aug; 32(15-16):5010-5027. PubMed ID: 37067394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.